A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies

Project: Research

Project Details

StatusFinished
Effective start/end date14/01/20 → 13/01/25

Keywords

  • clinical trial
  • phase 2 study
  • treatment efficacy
  • treatment safety
  • epilepsy

Clinical Trial Phase

  • Phase II